产品名称 | NebuSelect™ Recombinant Human ADAM9, His-tag |
---|---|
目录号 | NBL-243129 |
别名 | ADAM9; ADAM 9; Meltrin-gamma; Mdc9; Mltng; Adam9; Kiaa0021; AU020942; MDC9; mKIAA0021; CORD9; MCMP; MLTNG |
外观 | see COA |
分子量 | Ala29-Asp697 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q13443-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-243129-100ug | 100ug | Inquire | Inquire | |
NBL-243129-1mg | 1mg | Inquire | Inquire | |
NBL-243129-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human ADAM9, His-tag
Catalog#:
NBL-243129
Description:
NebuSelect™ Recombinant Human ADAM9, His-tag(Cat#NBL-243129) is expressed in HEK293 with His tag at the C-Terminus.It contains Ala29-Asp697.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 77.95 kDa. Due to furin cleavage site, the mature form migrates to 40-45 kDa and 60-70 kDa based on Bis-Tris PAGE result.
Target Name:
ADAM9; ADAM 9; Meltrin-gamma; Mdc9; Mltng; Adam9; Kiaa0021; AU020942; MDC9; mKIAA0021; CORD9; MCMP; MLTNG
Target Information:
A disintegrin and metalloproteinase 9 (ADAM9) is a member of the transmembrane ADAM family. It is expressed in different types of solid cancer and promotes tumor invasiveness. ADAM9 may be a prognostic marker for vestibular schwannomas (VS), and ADAM9 inhibition might have the potential as a systemic approach for the treatment of VS.
Amino Acid Sequence:
Ala29-Asp697
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.